-
Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall
Friday, January 12, 2018International Laboratories, LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Clopidogrel Tablets USP, 75 mg but may contain Clopidogrel 75mg or Simvastatin Tablets USP 10 mg.
Missed doses of Clopidogrel increases the risk of heart attack and stroke which can be life threatening.
Read More
Home
- About
- Careers
- Contact Us
- Medicare Quality Improvement (QIO)
- HSAG HQIC Partnership
-
ESRD Networks Home
- About Us
- Contact Us
- For Patients and Families
- For Providers
- ESRD Network 7
- ESRD Network 13
- ESRD Network 15
- ESRD Network 17
- ESRD Network 18
- HSAG ESRD Alerts, Recalls, and Notices
- Behavioral Health
- Continuing Education
- Data Management
- Emergency Preparedness
- Home Dialysis
- Infection Prevention
- Patient and Family Engagement (PFE)
- Readmissions and Hospitalizations
- Telemedicine
- Transplant
- Vaccinations
- Healthcare Policy and Quality Measurement
- Medicaid External Quality Review
- QPP Service Center
- Surveys
- Audit and Validation Services (HEDIS®/AMP)
- News